India’s first indigenous COVID-19 vaccine "COVAXIN’ is developed by BBIL in collaboration with the Indian Council of Medical Research (ICMR) - National Iastitute of Virology (NIV). The ‘BBIL’ is stand for -

Correct option is C

• BBIL stands for Bharat Biotech International Limited, a Hyderabad-based biotechnology company.
• Bharat Biotech played a pivotal role in developing India's first indigenous COVID-19 vaccine, COVAXIN, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
• COVAXIN is a whole-virion inactivated vaccine that has been extensively tested and widely distributed during the COVID-19 pandemic.

Information Booster

• COVAXIN is an inactivated vaccine developed using the SARS-CoV-2 virus isolated by NIV.
• Bharat Biotech has a history of creating vaccines for various diseases like rotavirus, typhoid, and rabies.
• The company adheres to WHO Good Manufacturing Practices (GMP) in vaccine production.